Validation Study of Physical Measurement of Tophi
NCT00175006 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 13
Last updated 2010-07-27
Summary
The purpose of this study is to determine the inter- and intra-rater reproducibility of direct physical measurement of tophus nodules in subjects with gout.
Conditions
Interventions
- OTHER
-
Measurement of Tophi to validate procedure
Intra- and Inter-rater Reproducibility measurements of the area (in mm2) of each tophus nodule.
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Medical Director · Takeda
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-11-30
- Primary Completion
- 2003-01-31
- Completion
- 2003-01-31
More Related Trials
-
Combination Treatment Study in Subjects With Tophaceous Gout With Lesinurad and Febuxostat
NCT01510769 ·Status: COMPLETED ·Phase: PHASE3
-
Low-dose Colchicine With or Without Stepwise Dose Titration of Febuxostat for Flare Prophylaxis in Gout
NCT04697602 ·Status: TERMINATED ·Phase: NA
-
Evaluating the Effectiveness of a Chronic Disease Management Program for Gout
NCT01568879 ·Status: COMPLETED ·Phase: NA
-
Effect of Febuxostat on Joint Damage in Hyperuricemic Subjects With Early Gout
NCT01078389 ·Status: COMPLETED ·Phase: PHASE2
-
MRI and Ultrasound Findings in Patients With Gout and Normal Plain Radiographs
NCT00584311 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study of MBX-102 in Treatment of Hyperuricemia in Patients With Gout
NCT01336686 ·Status: COMPLETED ·Phase: PHASE2
-
UR+AIMS Gout Wearable Skin Uric Acid Monitor Study
NCT06187519 ·Status: COMPLETED ·Phase: NA
-
The Remote Monitoring of Gout Feasibility Study
NCT06211322 ·Status: COMPLETED ·Phase: NA
-
Arthritis Research UK Gout Treatment Trial - Phase 2
NCT01477346 ·Status: COMPLETED ·Phase: NA
-
Musculoskeletal Ultrasound in Asymptomatic Hyperuricemia
NCT02502565 ·Status: UNKNOWN
-
Allopurinol in Acute Gout
NCT01775098 ·Status: WITHDRAWN ·Phase: NA
-
Study of of URC102 to Assess the Efficacy and Safety in Gout Patients
NCT04804111 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Febuxostat on Blood Pressure
NCT01496469 ·Status: COMPLETED ·Phase: PHASE2
-
Placebo Controlled, Multiple Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAP-001 in Gout Patients
NCT04040816 ·Status: COMPLETED ·Phase: PHASE2
-
Febuxostat Versus Allopurinol Control Trial in Subjects With Gout
NCT00102440 ·Status: COMPLETED ·Phase: PHASE3
-
Dose-Response, Safety and Efficacy of Febuxostat in Subjects With Gout
NCT00174967 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of RDEA806 in Hyperuricemic Subjects With Symptomatic Gout
NCT00741442 ·Status: COMPLETED ·Phase: PHASE2
-
A Nurse Led Patient Management Programme to Improve Outcomes in Gout
NCT03345186 ·Status: COMPLETED ·Phase: NA
-
Effect of Febuxostat on Renal Function in Patients With Gout and Moderate to Severe Renal Impairment
NCT01082640 ·Status: COMPLETED ·Phase: PHASE2
-
Single and Multiple Dose Study in Japanese Subjects
NCT01872832 ·Status: COMPLETED ·Phase: PHASE1
-
Placebo Controlled, Dose Escalation Study to Evaluate Safety, Pharmacokinetics & Efficacy of SAP-001 in Gout Patients
NCT03857165 ·Status: COMPLETED ·Phase: PHASE1
-
DECT Study in Allopurinol-Treated Gout Patients
NCT02393560 ·Status: COMPLETED
-
Study of the Correlation Between UltraSonography and Dual-Energy Computed Tomography Assessment of Urate Deposit
NCT03162341 ·Status: COMPLETED ·Phase: NA
-
Recapturing Immune Tolerance to Pegloticase for the Management of Tophaceous Gout
NCT06186219 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Oral Febuxostat in Participants With Gout
NCT00430248 ·Status: COMPLETED ·Phase: PHASE3